Modeling a Composite Score in Parkinson’s Disease Using Item Response Theory

• Published in: The AAPS journal Vol. 19; no. 3; pp. 837 - 845
• Main Authors: Gottipati, Gopichand, Karlsson, Mats O., Plan, Elodie L.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.05.2017
• Subjects: Adult; Aged; Aged, 80 and over; Biochemistry; Biomedical and Life Sciences; Biomedicine; Biotechnology; disease progression; Female; Humans; Item Response Theory; Male; Middle Aged; Models, Statistical; Movement Disorder Society (sponsored revision) Unified Parkinson's Disease Rating Scale; Parkinson Disease - diagnosis; Parkinson's disease; Pharmacology/Toxicology; Pharmacy; Research Article; Severity of Illness Index; Movement Disorder Society (sponsored revision) Unified Parkinson’s Disease Rating Scale; disease progression; Parkinson’s disease; Item Response Theory
• ISSN: 1550-7416; 1550-7416
• DOI: 10.1208/s12248-017-0058-8

In the current work, we present the methodology for development of an Item Response Theory model within a non-linear mixed effects framework to characterize the longitudinal changes of the Movement Disorder Society (sponsored revision) of Unified Parkinson’s Disease Rating Scale (MDS–UPDRS) endpoint in Parkinson’s disease (PD). The data were obtained from Parkinson’s Progression Markers Initiative database and included 163,070 observations up to 48 months from 430 subjects belonging to De Novo PD cohort. The probability of obtaining a score, reported for each of the items in the questionnaire, was modeled as a function of the subject’s disability. Initially, a single latent variable model was explored to characterize the disease progression over time. However, based on the understanding of the questionnaire set-up and the results of a residuals-based diagnostic tool, a three latent variable model with a mixture implementation was able to adequately describe longitudinal changes not only at the total score level but also at each individual item level. The linear progression rates obtained for the patient-reported items and the non-sided items were similar, each of which roughly take about 50 months for a typical subject to progress linearly from the baseline by one standard deviation. However for the sided items, it was found that the better side deteriorates quicker than the disabled side. This study presents a framework for analyzing MDS–UPDRS data, which can be adapted to more traditional UPDRS data collected in PD clinical trials and result in more efficient designs and analyses of such studies.